Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen
{{output}}
Background: 5q-associated spinal muscular atrophy (SMA) is a monogenic disease causing progressive alpha motor neuron degeneration, muscle atrophy, and weakness. Intrathecal therapy with the antisense oligonucleotide nusinersen m... ...
